Two new studies on Alzheimer’s disease currently recruiting participants

St. Joseph’s: Parkwood Institute - 

Two new interventional studies have been brought to London, focused on improving quality of life for patients with Alzheimer’s disease and their caregivers. Both hope to improve upon standard approaches to treating agitation, a core symptom of Alzheimer’s.

Agitation is a significant source of stress for patients and caregivers. It is complex and difficult to treat. Often, families do not know about this particular symptom of Alzheimer’s and are not properly trained on how to manage care while dealing with agitation. 

Laura Craven, PhD candidate, recognized for her leadership, clinical research and community involvement

Off­site - 

Laura Craven was presented with the Leadership Award for Fellows and Students at this year’s Lawson Impact Awards on April 11. This award recognizes individuals who demonstrate exceptional leadership qualities, strong research skills, and dedication to the advancement of health research.

The structured transition program Dr. Cheril Clarson (left) and Dr. Tamara Spaic (right) developed led to improved clinic attendance and satisfaction with care among young adult patients with type 1 diabetes. Nicole Pelcz (centre) was one of the patients enrolled in the study.

Study shows success of transition coordinator and need for continued intervention

In 2012, researchers from across Ontario, led by a team at Lawson Health Research Institute, started the first multicenter randomized controlled trial to evaluate implementation of a transition coordinator for young adults with type 1 diabetes as they transferred from paediatric to adult care.